8 companies

Bavarian Nordic

Market Cap: DKK 13.7b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 176.00

7D

-1.6%

1Y

-26.1%

H. Lundbeck

Market Cap: DKK 39.9b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 41.64

7D

-0.8%

1Y

19.6%

Novo Nordisk

Market Cap: DKK 1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NOVO B

DKK 293.85

7D

-11.2%

1Y

-4.9%

H. Lundbeck

Market Cap: DKK 39.9b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN A

DKK 35.75

7D

-1.0%

1Y

22.4%

Genmab

Market Cap: DKK 116.2b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,912.50

7D

3.7%

1Y

32.2%

Gubra

Market Cap: DKK 6.0b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

GUBRA

DKK 364.40

7D

-2.8%

1Y

0.8%

ALK-Abelló

Market Cap: DKK 49.1b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

ALK B

DKK 220.60

7D

-2.8%

1Y

19.2%

Strategic Partners

Market Cap: DKK 31.1m

Does not have significant operations.

New

STRAP

DKK 685.00

7D

-3.5%

1Y

-36.9%